You just read:

JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Trastuzumab Biosimilar to Treat Breast Cancer

News provided by

JHL Biotech

Aug 09, 2018, 21:24 ET